Class information for:
Level 1: HIGH DOSE CHEMOTHERAPY//DOSE INTENSITY//HIGH RISK BREAST CANCER

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
3825 1826 31.3 52%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
276 18466 BREAST CANCER//ACCELERATED PARTIAL BREAST IRRADIATION//PARTIAL BREAST IRRADIATION

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 HIGH DOSE CHEMOTHERAPY Author keyword 17 13% 7% 129
2 DOSE INTENSITY Author keyword 5 12% 2% 41
3 HIGH RISK BREAST CANCER Author keyword 5 47% 0% 8
4 AUTOLOGOUS STEM CELL SUPPORT Author keyword 4 67% 0% 4
5 CHEMO ENDOCRINE THERAPY Author keyword 4 75% 0% 3
6 CLASSICAL CMF Author keyword 3 100% 0% 3
7 HIGH RISK PRIMARY BREAST CANCER Author keyword 3 100% 0% 3
8 PROGENITOR CELL SUPPORT Author keyword 3 100% 0% 3
9 CHEMOENDOCRINE THERAPY Author keyword 3 35% 0% 6
10 CMF Author keyword 3 18% 1% 13

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 HIGH DOSE CHEMOTHERAPY 17 13% 7% 129 Search HIGH+DOSE+CHEMOTHERAPY Search HIGH+DOSE+CHEMOTHERAPY
2 DOSE INTENSITY 5 12% 2% 41 Search DOSE+INTENSITY Search DOSE+INTENSITY
3 HIGH RISK BREAST CANCER 5 47% 0% 8 Search HIGH+RISK+BREAST+CANCER Search HIGH+RISK+BREAST+CANCER
4 AUTOLOGOUS STEM CELL SUPPORT 4 67% 0% 4 Search AUTOLOGOUS+STEM+CELL+SUPPORT Search AUTOLOGOUS+STEM+CELL+SUPPORT
5 CHEMO ENDOCRINE THERAPY 4 75% 0% 3 Search CHEMO+ENDOCRINE+THERAPY Search CHEMO+ENDOCRINE+THERAPY
6 CLASSICAL CMF 3 100% 0% 3 Search CLASSICAL+CMF Search CLASSICAL+CMF
7 HIGH RISK PRIMARY BREAST CANCER 3 100% 0% 3 Search HIGH+RISK+PRIMARY+BREAST+CANCER Search HIGH+RISK+PRIMARY+BREAST+CANCER
8 PROGENITOR CELL SUPPORT 3 100% 0% 3 Search PROGENITOR+CELL+SUPPORT Search PROGENITOR+CELL+SUPPORT
9 CHEMOENDOCRINE THERAPY 3 35% 0% 6 Search CHEMOENDOCRINE+THERAPY Search CHEMOENDOCRINE+THERAPY
10 CMF 3 18% 1% 13 Search CMF Search CMF

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BONE MARROW SUPPORT 68 55% 5% 86
2 COMBINATION ALKYLATING AGENTS 37 73% 2% 29
3 CONVENTIONAL ADJUVANT CHEMOTHERAPY 28 81% 1% 17
4 MARROW SUPPORT 23 59% 1% 26
5 HISTORY DATA BASE 20 100% 0% 9
6 THIOTEPA 15 26% 3% 50
7 STEM CELL SUPPORT 15 33% 2% 37
8 CMF 13 36% 2% 29
9 DOXORUBICIN CYCLOPHOSPHAMIDE 13 47% 1% 20
10 PROGENITOR CELL SUPPORT 11 69% 0% 9

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
High dose chemotherapy for poor prognosis breast cancer: Systematic review and meta-analysis 2007 28 16 88%
SYSTEMIC TREATMENT OF EARLY BREAST-CANCER BY HORMONAL, CYTOTOXIC, OR IMMUNE THERAPY - 133 RANDOMIZED TRIALS INVOLVING 31000 RECURRENCES AND 24000 DEATHS AMONG 75000 WOMEN .2. 1992 700 13 46%
High-dose chemotherapy for high-risk primary and metastatic breast cancer: is another look warranted? 2009 19 45 64%
THE IMPORTANCE OF DOSE INTENSITY IN CHEMOTHERAPY OF METASTATIC BREAST-CANCER 1984 730 12 50%
Multiple-Treatments Meta-analysis of Chemotherapy and Targeted Therapies in Advanced Breast Cancer 2008 62 122 37%
A systematic overview of chemotherapy effects in breast cancer 2001 90 227 49%
Epirubicin: Is it like doxorubicin in breast cancer? A clinical review 2012 16 45 36%
Adjuvant breast cancer therapy: Current status and future strategies - Growth kinetics and the improved drug therapy of breast cancer 1999 36 15 53%
Addition of drug/s to a chemotherapy regimen for metastatic breast cancer 2010 6 30 53%
Dose-dense adjuvant chemotherapy for primary breast cancer 2005 16 18 72%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 RIO UNIV HOSP 2 67% 0.1% 2
2 SC ONCOL MED FALCK 2 67% 0.1% 2
3 INT ABORAT CANC GRP 1 50% 0.1% 2
4 REGISTRY GITMO DATA MANAGING 1 100% 0.1% 2
5 SPERIMENTAZ CLIN CONTROLLATE 1 100% 0.1% 2
6 W SWEDISH BREAST CANC STUDY GRP 1 33% 0.2% 3
7 BREAST GYNECOL CANC MED SERV 1 50% 0.1% 1
8 DIPARTIMENTO ONCOL RADIOTER IA 1 50% 0.1% 1
9 ICCG DATA 1 50% 0.1% 1
10 INT BREAST CANC STUDY GRP STAT FRONTIER SCI 1 50% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000198861 METASTATIC BREAST CANCER//VINORELBINE//DOCETAXEL
2 0.0000192571 N N N TRIETHYLENEPHOSPHORAMIDE//THIOTEPA MERCAPTURATE//TEPA
3 0.0000148034 PEGFILGRASTIM//FEBRILE NEUTROPENIA//FILGRASTIM
4 0.0000132614 ESTROGENIC RECRUITMENT//AMINOGLUTETHIMIDE//CYCLIC TREATMENT
5 0.0000085132 INFLAMMATORY BREAST CANCER//NEOADJUVANT CHEMOTHERAPY//LOCALLY ADVANCED BREAST CANCER
6 0.0000082098 PIROXANTRONE//MITOXANTRONE//PIXANTRONE
7 0.0000081490 NON COLORECTAL//STAGE IV BREAST CANCER//NON NEUROENDOCRINE
8 0.0000069619 PERITUMORAL VASCULAR INVASION//BLOOD VESSEL INVASION//AXILLARY NODE STATUS
9 0.0000069507 ER ICA//IMMUNOCYTOCHEMICAL ASSAY//PROGESTERONE RECEPTORS
10 0.0000050926 RADIATION INDUCED HEART DISEASE//POSTMASTECTOMY RADIOTHERAPY//CONTRALATERAL BREAST DOSE